DLDeze Li

Deze Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Deze Li has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Respiratory Haemophilus Influenzae in Henoch–Schönlein Purpura and Pneumonia: Capsular Type Associations in Children

    by Jing Hao, Hao Chen, Xiaotong Wang, Deze Li, Chen Shen

    Background. Haemophilus influenzae (Hi) is a common commensal of the pediatric respiratory tract and a lower-respiratory pathogen frequently detected in Henoch–Schönlein purpura (HSP, IgA vasculitis). Pathogenicity is largely capsule-determined, but the relationship between Hi capsular type and disease phenotype in children remains unclear. Methods. Detection rates were analyzed in a single-center cohort of 11,017 children who underwent bacterial nucleic-acid testing (HSP 2,596; other respiratory diseases 8,382; 39 with other respiratory diagnoses not entered into the comparisons), with 39 concurrently examined healthy children tested by the same assay as an external reference group. Hi-positive specimens were capsular-typed by an in-house two-step qPCR (bexA screening, then Region II multiplex, a–f). Associations were estimated by logistic regression with complementary age-confounding control and immune-status/testing-intensity sensitivity analyses; pathogenic potential was profiled in 44 reference genomes. Results. Hi detection was higher in HSP than in other respiratory diseases (57.0% vs 11.4%; adjusted OR 9.8, 95%CI 8.7–11.1) and healthy children (12.8%), consistent across age-handling methods and immune-normal subsets (ORs 7.8–9.8), and HSP-specific rather than severity-related. Capsular type spectra differed: HSP was relatively enriched for encapsulated type c (~50% vs 75–80% NTHi; OR 2.68–3.87). In pneumonia, NTHi patients were younger (median 3 vs 8 years) and more pneumonia-prone (74% vs 18%). Genomic pathogenic potential stratified by capsule; NTHi retained a rich virulence-factor repertoire. Conclusions. Respiratory Hi is highly detected in pediatric pneumonia and HSP, with distinct capsular type spectra and clear type–phenotype associations, consistent with capsule-dependent disease tropism. These associations are hypothesis-generating and require mechanistic validation.

  • Open Access

    Global and Super-Regional Burden of Mycoplasma pneumoniae–Attributable Lower Respiratory Infection Deaths in Children Aged 0–19 Years, 1990–2023: A Systematic Analysis of the Global Burden of Disease Study 2023

    by Chen Shen, Xiaotong Wang, Hao Chen, Deze Li

    Background. Mycoplasma pneumoniae, the archetypal agent of “walking pneumonia”, causes predominantly self-limited infection peaking in school-age children and adolescents, and is regarded as rarely fatal. After near-disappearance under pandemic non-pharmaceutical interventions in 2020–2021, re-emergence was delayed relative to other respiratory pathogens but was well established by 2023–2024. No standalone global estimate of M. pneumoniae–attributable mortality spanning the pandemic window has been reported to contextualise this resurgence. Methods. We analysed Global Burden of Disease (GBD) Study 2023 estimates (release v8352), which attribute lower respiratory infection (LRI) deaths to 26 pathogens through a counterfactual, population-attributable-fraction framework. Attributable deaths (the only available measure) were extracted globally and for seven super-regions, 1990–2023, for children aged 0–19 years (under 5, 5–9, 10–14, and 15–19 years). Trends were summarised by estimated annual percentage change (EAPC); 95% uncertainty intervals (UIs) were propagated conservatively. Reporting follows the GATHER statement. Results. In 2023, an estimated 26,382 deaths (95% UI 18,984–36,012) in children aged 0–19 years were attributable to M. pneumoniae, ranking ninth among 26 LRI aetiologies and accounting for 3.71% of all-pathogen LRI deaths. Deaths fell by 50.7% from 1990 to 2023 (EAPC −2.45% per year, 95% CI −2.66 to −2.23). Sub-Saharan Africa and South Asia carried 81.6% of the 2023 total. The 5–14 year share of attributable deaths was 15.0%, versus 2.2% for respiratory syncytial virus. Children under 5 years accounted for 80.6% of attributable deaths. Across the pandemic window, deaths fell only 17.1% in 2019–2021—versus 62.6% for influenza and 65.2% for respiratory syncytial virus—then rebounded 16.1% by 2023, exceeding the no-pandemic trend extrapolation by 19.2%. The crude mortality rate fell faster than counts (EAPC −2.93% per year), and estimates were stable across GBD rounds (≤2.6% difference for under-5 deaths).Conclusions. Modelled M. pneumoniae mortality concentrates where macrolide-resistance data and diagnostics are scarcest; its school-age skew and post-pandemic rebound are coherent with surveillance. These estimates provide baselines for age-targeted empirical-treatment guidance and resistance-aware stewardship.

  • Open Access

    No Spatially Resolvable Perivascular Monocyte Gradient in Healthy Human Lung: A Spatial-Transcriptomic Test of the Sustained-Extravasation Model of Interstitial Macrophage Renewal

    by Chen Shen, Deze Li, Hao Chen

    Background: Whether lung interstitial macrophages (IMs) are continuously replenished by blood-monocyte extravasation remains unresolved. We performed a hypothesis-driven secondary analysis of four public datasets. Methods: Dual-module scoring (MonoScore/ResidScore) was combined with vessel-distance gradient tests across the Madissoon 2023 healthy-lung atlas, the 10x PBMC 10k reference, and the Natri 2024 lung-disease cohort, using donor or slide as the statistical unit, spatially aware permutation nulls, and multiple-testing correction. Results: Among 40,634 healthy lung myeloid cells (34,912 in six axis populations), a continuous monocyte-to-resident axis placed perivascular IMs at the resident pole; batch-free intra-lung controls separated lung CD14 monocytes from perivascular IMs (AUC=0.9924), whereas cross-dataset AUCs are batch-confounded upper bounds not used for inference. Across three Visium slides (two donors), ResidScore signal per spot rose with vessel distance (3/3 slides concordant; toroidal-shift p=0.009-0.016, not surviving Bonferroni correction), while no slide showed the predicted monocyte-signal decay; block-level intervals were uninformative. In idiopathic pulmonary fibrosis (IPF), IM MonoScore was elevated (+0.088, p_adj=0.014 across 36 tests) without significant ResidScore loss or compositional change (p=0.68). Conclusions: This cross-sectional design cannot test ontogeny; it tests the spatial corollary of sustained extravasation, which steady-state adult human lung does not support — without contradicting mouse fate-mapping evidence, which addresses developmental and turnover-level origin. The perivascular niche emerges as a candidate renewal interface with a locally attenuated residency program. In IPF, IM monocytization reflects transcriptional reprogramming rather than compositional replacement.

  • Open Access

    CD10/Neprilysin as an Integrated Transcriptional Readout of Alveolar Macrophage Homeostatic Identity: A Multi-Dataset Secondary Analysis

    by Deze Li, Hao Chen, Chen Shen

    Background. Alveolar macrophages (AMs) are long-lived resident sentinels of the alveolar lumen. Yet no single surface readout coupled to their homeostatic program, with an explicit interpretation rule in disease, has been consolidated. CD10 (MME/neprilysin) is listed among human AM surface markers, but its performance as an identity readout and its biology have not been characterized across datasets, programs and disease states. We asked whether CD10 marks AM homeostatic identity, which programs it couples to, and how it changes in disease. Methods. We performed a secondary analysis of the Madissoon healthy human lung atlas and the Natri lung-disease atlas, with bronchoalveolar lavage (BAL) studies as literature-level reference. We quantified MME detection across compartments, co-expression programs, MME+/MME− dichotomized comparisons with sequencing-depth-matched controls, and donor-level disease statistics using the donor as the statistical unit. Results. CD10 marked resident AMs: MME was detected in 30.1% of AMs and 51.9% of proliferating AMs, versus 0.2–0.3% of monocytes. Within AMs, higher MME tracked the PPARγ lipid and TGFβ maturation programs (Pearson ρ = 0.296 with ITGB8, ρ = 0.209 with PPARG) together with a don’t-eat-me profile (3.20-fold PD-L1, 1.39-fold CD47); these couplings survived sequencing-depth-matched controls. At donor level, the MME–FABP4 coupling was reproduced (ρ = 0.472) whereas MME–PPARG was not. AM-compartment MME did not differ between idiopathic pulmonary fibrosis (IPF) and control (p = 0.92; 36 versus 44 donors), and no AM-compartment change survived FDR control in any diagnosis, whereas interstitial macrophage MME increased in IPF (p = 0.0003, FDR = 0.003) and non-IPF interstitial lung disease (p = 0.0042, FDR = 0.023). Conclusions. CD10 is a transcript-level candidate readout of AM homeostatic identity, co-expressed with the PPARγ lipid program and elevated don’t-eat-me signals. Disease-associated changes are compartment-specific, stable within AMs and induced within interstitial macrophages, consistent with compartment remodelling rather than wholesale loss; measured on tissue composition, dilution alone predicts that AM-dependent samples lose roughly half of their CD10 signal in fibrosis, quantitatively matching prior reports of resident AM depletion. Protein-level validation is pending.

  • Open Access

    Bipolar Displacement of the Lung Macrophage Ecosystem in Interstitial Lung Disease

    by Chen Shen, Deze Li, Hao Chen

    Background: In interstitial lung disease (ILD), alveolar macrophage loss and SPP1+ expansion have been described separately; the lost side (the homeostatic reservoir) is rarely quantified on a common scale or at donor level. We tested whether ILD remodels the lung macrophage ecosystem as a bipolar displacement of relative composition.Methods: A 25-module functional/morphological scoring system was applied to three scRNA-seq atlases (Madissoon normal lung, 40,634 myeloid cells; a PBMC reference; the Natri ILD atlas, 175,426 cells, 118 donors, 10 diagnoses, 30 microclusters), normal-lung Visium sections, 195,994 ligand-receptor edges and the independent IPF Cell Atlas (GSE136831), with donor-level statistics as the primary inferential unit.Results: Interstitial macrophages (IMs) were the most reprogrammed compartment, losing complement/phagocytic identity (up to -0.39) while gaining granuloma and matrix-remodelling programmes; sarcoidosis was the exception (complement +0.08; antigen presentation +0.31). C1Q-high reservoir microclusters, CD10/MME-high in their lipid-handling branch, contracted at donor level across all powered diagnoses, with disease-specific expansion of SPP1+ states; in IPF, donor-level tests supported a candidate SPP1/CHIT1-high state (mc26, 5.3% versus 0.39%; p=1.6×10-9; microcluster boundaries seed-sensitive) and a candidate OCSTAMP+ fusion-primed IM state. Ligand-receptor analysis indicated strengthened FN1-ITGB1/SPP1-CD44 axes and attenuated THBS1-CD36/C3 circuits; spatial data showed dispersed, non-aggregated homeostatic behaviour in normal lung; the expanding pole and the compositional anticorrelation replicated in the independent cohort, whereas programme-level identity loss did not.Conclusions: The ILD macrophage ecosystem exhibits a bipolar displacement of relative composition: a testable model of homeostatic-niche dissolution and pathological-niche construction.

  • Open Access

    Isoform Remodeling Along the Human Monocyte-to-Macrophage Differentiation Axis

    by Xiaotong Wang, Hao Chen, Deze Li, Chen Shen

    Tissue-resident macrophage diversity has been mapped at the gene-expression level, and alternative splicing has been catalogued across immune lineages [1,2]; isoform behavior along the monocyte-to-macrophage differentiation axis remains unexamined. Analyzing a 17-gene immune panel across BLUEPRINT differentiation series and GTEx v8, we identify an MSR1 isoform switch with complete donor-level separation (short-isoform fraction 0.844–0.914 in monocytes versus 0.291–0.541 in six macrophage samples; exact permutation p = 0.024) — a switch from the dominant-negative SR-AIII scavenger-receptor isoform to functional SR-AI/II receptors — with equally supported PTPRC, MYD88, and IRAK1 remodeling, whereas an IL1B canonical-fraction rise is donor-heterogeneous (p = 0.114). LY96 (MD-2) is induced ~17-fold during differentiation, yet the functionally decisive antagonist/agonist isoform ratio is not resolved by standard short-read annotation — a methodological gap for immune isoform studies. CD14/CD163 show dosage regulation without isoform switching: CD163 peaks in LPS-driven M1 macrophages and, in human brain, marks border-associated macrophages rather than microglia. A 62-gene cytoskeletal panel nominates septin-family isoform divergence as a candidate mechanism of the ramified-to-amoeboid morphology spectrum, with PTBP1/hnRNP/SRSF programs as candidate executors of immune-side switching. Differentiation-coupled isoform remodeling is thus a component of macrophage identity.

  • Open Access

    Dual Macrophage Programs in Pulmonary Fibrosis: Functional Attribution and Spatial Resolution of Iron-Handling/Efferocytosis FOLR2+ and Scar-Associated SPP1+ Axes

    by Chen Shen, Deze Li, Hao Chen

    Background: A dual-axis organization of non-alveolar macrophages—scar-associated SPP1+ and tissue-resident-like FOLR2+ populations—was recently delineated in idiopathic pulmonary fibrosis (IPF), but their functions and niches remain unresolved. Methods: We integrated full-transcriptome re-clustering of the GSE135893 myeloid compartment, independent replication (GSE136831), and GeoMx spatial profiling of bronchiolitis obliterans and fibrosing ILD lesions (GSE316672, GSE255174). Results: Two IPF-emergent entities were confirmed and first systematically quantified: SPP1+/TREM2+ scar-associated macrophages (97% IPF-derived; 4.0% to 30.7% of macrophages) and the FOLR2+/CD163+/SLC40A1+ iron-handling population (95% IPF; 11.9% to 19.0%). Both axes replicated in the Adams cohort (donor-level p = 1.2 × 10⁻⁵ and 8.2 × 10⁻¹¹). Spatial profiling revealed a core-and-ring architecture in BO lesions (SPP1+/TREM2+ luminal core; MCL1-high scavenger ring). Monocyte flux correlated with fibroblast apoptotic priming (rho = +0.54; nominal p = 0.045). No canonical M1/M2a enrichment was detected; the FOLR2+ efferocytosis arm was MERTK/GAS6-dominant across cohorts. Conclusion: The fibrotic lung’s dual-axis macrophage architecture is functionally attributed and spatially resolved, with implications for combination targeting.

  • Open Access

    Shared and Disease-Specific Monocyte eQTLs Across Inflammatory Conditions

    by Chen Shen, Deze Li, Hao Chen

    Background: Expression quantitative trait loci (eQTLs) carry a disproportionate share of autoimmune disease heritability, yet whether genetic regulation differs across inflammatory diseases within one cell type is unknown. Cross-disease comparison of monocyte eQTLs has not been performed with harmonized processing and power-calibrated specificity, and the ten-fold range of cohort sample sizes makes naive comparisons vulnerable to false specificity.Methods: We harmonized monocyte cis-eQTL summary statistics from five public resources spanning healthy, lupus-enriched, influenza-stimulated, and inflammatory bowel disease contexts; quantified power and false specificity by simulation; and decomposed effect sharing with multivariate adaptive shrinkage (mashR) and a variance-based specificity index.Results: In simulation, naive per-condition significance calls misclassify 72.6% of truly shared eQTLs as disease-specific; cross-condition borrowing reduces this to 13.0%, and a high-confidence specificity criterion to 0.005%. A three-condition pilot run (1,671,712 gene–variant pairs) passed all quality-control gates, and the full-scale seven-condition run (3,277,117 pairs) confirmed the patterns at scale across the healthy, SLE-cohort, and influenza axes: data-driven covariance structures dominated the fitted mixture (combined weight 0.9471), 2,737,644 pairs (83.5% of the strong set) remained significant under the joint model, and 16.87% of pairs were high-confidence specific under the tested-mask-aware criterion (16.90% after adjudication-layer MHC exclusion), within the pre-registered 20% ceiling under both configurations and in all 18 cells of the adjudication sensitivity grid, with MHC-region and 17q21.31 genes top-ranked. Magnitude sharing was highest within studies (within-study mean 0.859 versus cross-study mean 0.345; Randolph non-infected versus influenza-exposed 0.953, Perez classical versus non-classical 0.899). Pre-registered arbitration diagnostics (PCA and hierarchical clustering of the posterior mean matrix) grouped conditions by study of origin rather than by health-versus-disease status; under the pre-registered scenario-C rule, cross-cohort disease-specificity claims therefore contract to within-study paired contrasts. In the paired Randolph cohort—the single design in which disease state is unconfounded with cohort—influenza exposure and infection left the monocyte eQTL landscape nearly intact: sign concordance between the non-infected and infected states was 99.7% among jointly significant pairs, magnitude sharing was 0.89–0.95, and effect amplitudes were attenuated with infection (median posterior-effect ratio, non-infected over infected, 1.31), while 71,107 pairs (2.2% of the strong set) were high-confidence specific to the influenza axis. Conclusions: This study establishes and validates a power-calibrated framework for cross-disease regulatory genetics at full scale. Because disease context is confounded with cohort, ancestry, and platform in the current design and the pre-registered discriminating diagnostics show study-of-origin grouping, cross-cohort disease-specificity claims contract to within-study paired contrasts under the pre-registered rule. Within the one paired disease-state design available, influenza exposure and infection produce graded amplitude modulation on an almost completely shared regulatory backbone rather than wholesale regulatory rewiring; whether healthy-reference maps systematically miss disease-context regulation beyond such amplitude effects cannot be decomposed from cohort effects here. Disease-stratified heritability partitioning and locus-level nomination are pre-registered and in progress.

  • Open Access

    Pan-Cancer Immunogenomic Quantification of T and NK Cell Barriers in Solid Tumors Reveals Stromal–Metabolic Bottlenecks for Adoptive Cell Therapy

    by Chen Shen, Hao Chen, Deze Li

    Adoptive cell therapy (ACT) has transformed the treatment of hematological malignancies but largely fails against solid tumors; the biological basis of this divide has rarely been quantified across cancer types. We analyzed uniformly reprocessed RNA-seq data (Toil pipeline) from TCGA (9,359 tumors, 33 cancer types), TARGET (734 pediatric tumors), and GTEx (7,862 normal samples). A 132-gene panel yielded T/natural killer (NK) infiltration, functional, metabolic, and stromal scores, integrated into a composite Solid Tumor Immune Accessibility Score (STIAS); six public single-cell datasets provided cellular validation. Median T- and NK-cell infiltration was about 30% lower in solid than in hematological tumors—a gap reflecting tissue of origin rather than recruitment failure. Single-cell analysis revealed per-cell enrichment of exhausted T-cell programs in solid tumors (23.6% versus 8.9%) and NKG2A upregulation on colorectal-tumor NK cells, while the dominant cohort-level barriers were stromal (extracellular matrix 3.79-fold) and metabolic (IDO pathway 1.27-fold). STIAS classified 14.5% of solid tumors as hematological-like “Accessible” phenotypes—reproduced in the pediatric TARGET cohort and enriched for the C2 (IFN-γ–dominant) immune subtype (26.4% versus 3.5%)—with each 0.1-unit increase associating with 46% and 40% higher hazard of death and progression. A bidirectional target atlas validated epithelial antigens (MUC1, ERBB2, CLDN18, CEACAM5, FAP, CD73) at the protein level and mapped hematological off-tumor risks; hematological-lineage signals (CD38, BCMA) proved predominantly immune-infiltrate-derived. Stromal–metabolic barriers dominate the solid tumor–specific axes of ACT resistance; STIAS-guided stratification and microenvironment reprogramming may extend cellular immunotherapy to solid malignancies.